{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T04:02:48Z","timestamp":1744430568664,"version":"3.40.4"},"reference-count":68,"publisher":"Wiley","issue":"S286","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R 108 A7021 14S31"],"award-info":[{"award-number":["R 108 A7021 14S31"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005940","name":"Dansk Kr\u00e6ftforsknings Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010347","name":"Fabrikant Einar Willumsens Mindelegat","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019562","name":"Synoptik-Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF15OC0014158"],"award-info":[{"award-number":["NNF15OC0014158"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>ENGLISH SUMMARY<\/jats:title><jats:p>Allogeneic haematopoietic stem cell transplantation (HSCT) is used to cure both malignant and non\u2010malignant haematological diseases. Despite HSCT has been available for more than 50\u2009years, chronic graft\u2010versus\u2010host disease (cGVHD) remains a difficult immunologically mediated challenge, which increases morbidity and mortality after transplantation. When cGVHD targets the eyes, it causes reduced tears and inflammation which lead to red, irritated eyes, corneal damage and blindness in worst cases. Ocular cGVHD significantly reduces quality of life after HSCT. We need to gain further knowledge about this disease to help this patient group.<\/jats:p><jats:p>The overall aim of this PhD project was to investigate the incidence and risk factors for developing ocular cGVHD in both adults and children. Furthermore, the objective was to investigate possible associations between ocular cGVHD and cGVHD in other organs, and mortality after HSCT.<\/jats:p><jats:p>A conditioning regimen is given to the patient before transplantation, which can be either myeloablative (MA) or non\u2010myeloablative (NMA). Our studies showed that in adults, the 5\u2010year cumulative incidence of ocular cGVHD was 18% after MA and 35% after NMA regimen. Several factors were associated with a higher risk of ocular cGVHD after both conditioning regimens. In the MA group, malignant disease, Schirmer's test \u226410\u2009mm\/5\u2009min before HSCT, the use of a matched unrelated donor or female donor, peripheral blood as stem cell source and acute GVHD (grade III\u2013IV) increased the risk of ocular cGVHD. In the NMA group, Schirmer's test \u226410\u2009mm\/5\u2009min before transplantation and higher recipient age increased the risk of ocular cGVHD. In children, the incidence of ocular cGVHD was 6% and therefore less common than in adults. Ocular cGVHD was more frequent in patients with extensive cGVHD, and when other ectodermal derived organs were involved (skin, mouth, genitals and nails). The frequency of ocular cGVHD was especially high in patients with skin sclerosis as a manifestation of cGVHD (70%). Our studies suggest that target antigens in ectodermal derived organs might be involved in the complex pathophysiology of ocular cGVHD, but more studies are needed to explore this. Ocular cGVHD was furthermore found to be associated with a higher non\u2010relapse mortality.<\/jats:p><jats:p>In conclusion, several risk factors for developing ocular cGVHD exists. This knowledge may be applied to guide clinical trials (i.e. power calculations), to inform patients of their risk of developing ocular cGVHD and to guide clinicians in scheduling patient follow\u2010up. Because of the many patients with signs of dry eyes before HSCT (which increase the risk of ocular cGVHD), we recommend performing a baseline ophthalmological examination before HSCT.<\/jats:p><jats:p>More studies are needed to elucidate the pathophysiology of ocular GVHD. In the future, this could lead to better treatment options and potentially prevention of the disease.<\/jats:p>","DOI":"10.1111\/aos.17452","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T06:15:38Z","timestamp":1744352138000},"page":"3-19","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ocular graft\u2010versus\u2010host disease: Risk factors of ocular graft\u2010versus\u2010host disease after allogeneic haematopoietic stem cell transplantation in Denmark"],"prefix":"10.1111","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7972-3698","authenticated-orcid":false,"given":"Helene","family":"Jeppesen","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Rigshospitalet Copenhagen University Hospital  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/ije\/dyr213","article-title":"Competing risks in epidemiology: possibilities and pitfalls","volume":"41","author":"Andersen P.K.","year":"2012","journal-title":"International Journal of Epidemiology"},{"key":"e_1_2_13_3_1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.icu.0000143684.22362.46","article-title":"Ocular manifestations of graft versus host disease","volume":"15","author":"Anderson N.G.","year":"2004","journal-title":"Current Opinion in Ophthalmology"},{"key":"e_1_2_13_4_1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/bbmt.2002.v8.pm12374452","article-title":"Busulfan systemic exposure relative to regimen\u2010related toxicity and acute graft\u2010versus\u2010host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia","volume":"8","author":"Andersson B.S.","year":"2002","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"e_1_2_13_5_1","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1182\/bloodadvances.2019000934","article-title":"Using a machine learning algorithm to predict acute graft\u2010versus\u2010host disease following allogeneic transplantation","volume":"3","author":"Arai Y.","year":"2019","journal-title":"Blood Advances"},{"key":"e_1_2_13_6_1","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo A.","year":"2009","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"e_1_2_13_7_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.12968\/hmed.2019.80.1.33","article-title":"Haematopoietic stem cell transplants: principles and indications","volume":"80","author":"Balassa K.","year":"2019","journal-title":"British Journal of Hospital Medicine"},{"key":"e_1_2_13_8_1","first-page":"e526","article-title":"Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis","volume":"3","author":"Bartelink I.H.","year":"2016","journal-title":"The Lancet"},{"key":"e_1_2_13_9_1","doi-asserted-by":"crossref","DOI":"10.3390\/biom14010102","article-title":"Molecular biomarkers in ocular graft\u2010versus\u2010host disease: a systematic review","volume":"14","author":"Bohlen J.","year":"2024","journal-title":"Biomolecules"},{"key":"e_1_2_13_10_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-030-02278-5_11","volume-title":"The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies","author":"Carreras E.","year":"2019"},{"key":"e_1_2_13_11_1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1092108","article-title":"Recent advances in ocular graft\u2010versus\u2010host disease","volume":"14","author":"Cheng X.","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"e_1_2_13_12_1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","article-title":"The biology of chronic graft\u2010versus\u2010host disease: a task force report from the National Institutes of Health consensus development project on criteria for clinical trials in chronic graft\u2010versus\u2010host disease","volume":"23","author":"Cooke K.R.","year":"2017","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"e_1_2_13_13_1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig J.P.","year":"2017","journal-title":"The Ocular Surface"},{"key":"e_1_2_13_14_1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ICO.0b013e318226bf97","article-title":"Diagnosis and treatment of ocular chronic graft\u2010versus\u2010host disease: report from the German\u2010Austrian\u2010Swiss Consensus Conference on clinical practice in chronic GVHD","volume":"31","author":"Dietrich\u2010Ntoukas T.","year":"2012","journal-title":"Cornea"},{"key":"e_1_2_13_15_1","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft\u2010versus\u2010host disease","volume":"373","author":"Ferrara J.L.","year":"2009","journal-title":"Lancet"},{"key":"e_1_2_13_16_1","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1200\/JCO.2008.17.6545","article-title":"Risk factors for acute graft\u2010versus\u2010host disease after human leukocyte antigen\u2010identical sibling transplants for adults with leukemia","volume":"26","author":"Hahn T.","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_13_17_1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/hematology.2021000301","article-title":"Updates in chronic graft\u2010versus\u2010host disease","volume":"2021","author":"Hamilton B.K.","year":"2021","journal-title":"Hematology"},{"key":"e_1_2_13_18_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft\u2010versus\u2010host disease clinical data collection: a report from the Mount Sinai acute GVHD international consortium","volume":"22","author":"Harris A.C.","year":"2016","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"e_1_2_13_19_1","unstructured":"Heegaard S. Knudsen L. Setten G.&Moilanan J.(2022)Dry eye disease Nordic guidelines.https:\/\/dansk\u2010oftalmologisk\u2010selskab.dk\/wp\u2010content\/uploads\/2022\/06\/2022\u201011\u201003\u2010Nordic\u2010Guideline.pdf."},{"key":"e_1_2_13_20_1","first-page":"1","article-title":"Antigen\u2010based immunotherapy for autoimmune disease: current status","volume":"4","author":"Hirsch D.L.","year":"2015","journal-title":"ImmunoTargets and Therapy"},{"key":"e_1_2_13_21_1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft\u2010versus\u2010leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz M.M.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_13_22_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2018.11.021","article-title":"Ocular graft\u2010versus\u2010host disease after hematopoietic cell transplantation: expert review from the late effects and quality of life working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of blood and marrow transplantation","volume":"25","author":"Inamoto Y.","year":"2019","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"e_1_2_13_23_1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/archopht.1989.01070020413046","article-title":"The eye in bone marrow transplantation. III. Conjunctival graft\u2010vs\u2010host disease","volume":"107","author":"Jabs D.A.","year":"1989","journal-title":"Archives of Ophthalmology"},{"key":"e_1_2_13_24_1","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/bmt.2012.56","article-title":"Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria","volume":"47","author":"Jacobs R.","year":"2012","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_13_25_1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1172-2-35","article-title":"Acute graft versus host disease","volume":"2","author":"Jacobsohn D.A.","year":"2007","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"e_1_2_13_26_1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3181\/00379727-70-17053","article-title":"The role of the spleen in radiation injury. Proceedings of the Society for Experimental Biology and Medicine","volume":"70","author":"Jacobson L.O.","year":"1949","journal-title":"Society for Experimental Biology and Medicine"},{"issue":"389","key":"e_1_2_13_27_1","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft\u2010versus\u2010host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia M.H.","year":"2015","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"e_1_2_13_28_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.08.016","article-title":"Ocular chronic graft\u2010versus\u2010host disease and its relation to other organ manifestations and outcomes after allogeneic hematopoietic cell transplantation","volume":"28","author":"Jeppesen H.","year":"2022","journal-title":"Transplantation and Cellular Therapy"},{"key":"e_1_2_13_29_1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41409-022-01564-2","article-title":"Ocular graft\u2010versus\u2010host disease and dry eye disease after paediatric haematopoietic stem cell transplantation\u2014incidence and risk factors","volume":"57","author":"Jeppesen H.","year":"2022","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_13_30_1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41409-020-0993-3","article-title":"Chronic ocular graft\u2010versus\u2010host disease after allogeneic haematopoietic stem cell transplantation in Denmark\u2014factors associated with risks and rates in adults according to conditioning regimen","volume":"56","author":"Jeppesen H.","year":"2021","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_13_31_1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/ceo.14347","article-title":"How does ocular graft\u2010versus\u2010host disease fit under the dry eye umbrella? A review","volume":"52","author":"Kantor N.B.","year":"2024","journal-title":"Clinical & Experimental Ophthalmology"},{"key":"e_1_2_13_32_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1542-0124(12)70102-7","article-title":"Signaling pathways in morphogenesis of cornea and eyelid","volume":"6","author":"Kao W.W.","year":"2008","journal-title":"The Ocular Surface"},{"key":"e_1_2_13_33_1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.icu.0000233952.09595.d8","article-title":"Update on ocular graft versus host disease","volume":"17","author":"Kim S.K.","year":"2006","journal-title":"Current Opinion in Ophthalmology"},{"key":"e_1_2_13_34_1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bmt.1703260","article-title":"Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis","volume":"28","author":"Klein J.P.","year":"2001","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_13_35_1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jclinepi.2012.09.017","article-title":"A competing risks analysis should report results on all cause\u2010specific hazards and cumulative incidence functions","volume":"66","author":"Latouche A.","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"e_1_2_13_36_1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/asheducation-2008.1.134","article-title":"Recognizing and managing chronic graft\u2010versus\u2010host disease","volume":"2008","author":"Lee S.J.","year":"2008","journal-title":"Hematology"},{"key":"e_1_2_13_37_1","first-page":"145","article-title":"Sleep quality in patients with ocular graft\u2010versus\u2010host disease after allogeneic hematopoietic stem cell transplantation","volume":"50","author":"Liao Y.","year":"2024","journal-title":"Eye & Contact Lens"},{"key":"e_1_2_13_38_1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40164-021-00240-3","article-title":"Roles of the intestinal microbiota and microbial metabolites in acute GVHD","volume":"10","author":"Lin D.","year":"2021","journal-title":"Experimental Hematology & Oncology"},{"key":"e_1_2_13_39_1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrc748","article-title":"History of haematopoietic stem\u2010cell transplantation","volume":"2","author":"Little M.T.","year":"2002","journal-title":"Nature Reviews Cancer"},{"key":"e_1_2_13_40_1","first-page":"197","article-title":"Modification of irradiation injury in mice and Guinea pigs by bone marrow injections","volume":"12","author":"Lorenz E.","year":"1951","journal-title":"Journal of the National Cancer Institute"},{"key":"e_1_2_13_41_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","article-title":"Acute graft\u2010versus\u2010host disease","volume":"9","author":"Malard F.","year":"2023","journal-title":"Nature Reviews Disease Primers"},{"key":"e_1_2_13_42_1","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/ajh.27040","article-title":"Updates in chronic graft\u2010versus\u2010host disease management","volume":"98","author":"Malard F.","year":"2023","journal-title":"American Journal of Hematology"},{"key":"e_1_2_13_43_1","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","article-title":"Sclerotic\u2010type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease","volume":"118","author":"Martires K.J.","year":"2011","journal-title":"Blood"},{"issue":"277","key":"e_1_2_13_44_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/aos.15739","article-title":"Mesenchymal stem cell therapy in aqueous deficient dry eye disease","volume":"101","author":"M\u00f8ller\u2010Hansen M.","year":"2023","journal-title":"Acta Ophthalmologica"},{"key":"e_1_2_13_45_1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/CCO.0000000000000996","article-title":"Machine learning applications and challenges in graft\u2010versus\u2010host disease: a scoping review","volume":"35","author":"Mushtaq A.H.","year":"2023","journal-title":"Current Opinion in Oncology"},{"key":"e_1_2_13_46_1","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/bmt.2015.187","article-title":"Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation","volume":"50","author":"Na K.S.","year":"2015","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_13_47_1","volume-title":"The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies","author":"Nagler A.","year":"2019"},{"key":"e_1_2_13_48_1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3324\/haematol.2021.279189","article-title":"One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non\u2010identical family donors","volume":"107","author":"Niederwieser D.","year":"2022","journal-title":"Haematologica"},{"key":"e_1_2_13_49_1","unstructured":"NobelPrize.org. (2024)Nobel Prize Outreach AB 2024. The Nobel Prize in Physiology or Medicine 1990.https:\/\/www.nobelprize.org\/prizes\/medicine\/1990\/summary\/"},{"key":"e_1_2_13_50_1","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1038\/srep03419","article-title":"International chronic ocular graft\u2010vs\u2010host\u2010disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (part I)","volume":"3","author":"Ogawa Y.","year":"2013","journal-title":"Scientific Reports"},{"key":"e_1_2_13_51_1","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1167\/iovs.05-0227","article-title":"Donor fibroblast chimerism in the pathogenic fibrotic lesion of human chronic graft\u2010versus\u2010host disease","volume":"46","author":"Ogawa Y.","year":"2005","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"e_1_2_13_52_1","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1167\/iovs.02-0699","article-title":"Periductal area as the primary site for T\u2010cell activation in lacrimal gland chronic graft\u2010versus\u2010host disease","volume":"44","author":"Ogawa Y.","year":"2003","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"e_1_2_13_53_1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.bmt.1703862","article-title":"Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft\u2010versus\u2010host disease","volume":"31","author":"Ogawa Y.","year":"2003","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_13_54_1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ajo.2021.02.022","article-title":"Incidence, risk factors and complications of ocular graft\u2010versus\u2010host disease following hematopoietic stem cell transplantation: incidence, risk factors and complications of ocular GVHD","volume":"227","author":"Pellegrini M.","year":"2021","journal-title":"American Journal of Ophthalmology"},{"key":"e_1_2_13_55_1","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka D.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_13_56_1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/ICO.0000000000001109","article-title":"Validation of international chronic ocular graft\u2010versus\u2010host disease (GVHD) group diagnostic criteria as a chronic ocular GVHD\u2010specific metric","volume":"36","author":"Rapoport Y.","year":"2017","journal-title":"Cornea"},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltab009"},{"key":"e_1_2_13_58_1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/ICU.0b013e32833eab64","article-title":"Current insights into ocular graft\u2010versus\u2010host disease","volume":"21","author":"Riemens A.","year":"2010","journal-title":"Current Opinion in Ophthalmology"},{"key":"e_1_2_13_59_1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/aos.12047","article-title":"Impact of ocular graft\u2010versus\u2010host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study","volume":"92","author":"Riemens A.","year":"2014","journal-title":"Acta Ophthalmologica"},{"key":"e_1_2_13_60_1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF02982052","article-title":"Ocular manifestation of acute graft\u2010versus\u2010host disease after allogeneic peripheral blood stem cell transplantation","volume":"75","author":"Saito T.","year":"2002","journal-title":"International Journal of Hematology"},{"key":"e_1_2_13_61_1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease index","volume":"118","author":"Schiffman R.M.","year":"2000","journal-title":"Archives of Ophthalmology"},{"key":"e_1_2_13_62_1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.survophthal.2012.08.004","article-title":"Ocular graft\u2010versus\u2010host disease: a review","volume":"58","author":"Shikari H.","year":"2013","journal-title":"Survey of Ophthalmology"},{"key":"e_1_2_13_63_1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","article-title":"NIH consensus development project on criteria for clinical trials in chronic graft\u2010versus\u2010host disease: II. The 2014 pathology working group report","volume":"21","author":"Shulman H.M.","year":"2015","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"e_1_2_13_64_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbmt.2005.10.023","article-title":"Histopathologic diagnosis of chronic graft\u2010versus\u2010host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft\u2010versus\u2010host disease: II. Pathology working group report","volume":"12","author":"Shulman H.M.","year":"2006","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"e_1_2_13_65_1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin S.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_13_66_1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/bmt.2015.6","article-title":"Indications for allo\u2010 and auto\u2010SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015","volume":"50","author":"Sureda A.","year":"2015","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_13_67_1","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.ophtha.2009.04.054","article-title":"Ocular findings after allogeneic hematopoietic stem cell transplantation","volume":"116","author":"Tabbara K.F.","year":"2009","journal-title":"Ophthalmology"},{"key":"e_1_2_13_68_1","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1136\/bjophthalmol-2014-306438","article-title":"Risk factors for the development of ocular graft\u2010versus\u2010host disease (GVHD) dry eye syndrome in patients with chronic GVHD","volume":"99","author":"Wang J.C.","year":"2015","journal-title":"The British Journal of Ophthalmology"},{"key":"e_1_2_13_69_1","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/ICO.0b013e3181ca321c","article-title":"Ocular graft\u2010versus\u2010host disease after allogeneic stem cell transplantation","volume":"29","author":"Westeneng A.C.","year":"2010","journal-title":"Cornea"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.17452","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T06:15:52Z","timestamp":1744352152000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aos.17452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":68,"journal-issue":{"issue":"S286","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1111\/aos.17452"],"URL":"https:\/\/doi.org\/10.1111\/aos.17452","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2025-01-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}